Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Radiation absorbed dose calculation of Lu-177-DOTA-TATE therapy in patients with somatostatin receptor expressing tumors

Nami Yeyin, Handan Tanyildizi, Emre Demirci, Resit Akyel, Aslan Aygun, Turkay Toklu, Meltem Ocak, Levent Kabasakal and Bedii Kanmaz
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1027;
Nami Yeyin
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Handan Tanyildizi
2Department of Nuclear Physics, Faculty of Sciences, Istanbul University, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emre Demirci
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Resit Akyel
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aslan Aygun
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Turkay Toklu
3Department of Nuclear Medicine, Yeditepe University Medical School, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meltem Ocak
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Levent Kabasakal
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bedii Kanmaz
1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1027

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Nami Yeyin1,
  2. Handan Tanyildizi2,
  3. Emre Demirci1,
  4. Resit Akyel1,
  5. Aslan Aygun1,
  6. Turkay Toklu3,
  7. Meltem Ocak1,
  8. Levent Kabasakal1 and
  9. Bedii Kanmaz1
  1. 1Department of Nuclear Medicine, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
  2. 2Department of Nuclear Physics, Faculty of Sciences, Istanbul University, Istanbul, Turkey
  3. 3Department of Nuclear Medicine, Yeditepe University Medical School, Istanbul, Turkey

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014900
Jan 2015400
Feb 2015100
Jun 2015500
Jul 2015400
Aug 2015300
Sep 2015500
Nov 2015100
Dec 2015100
Jan 2016200
Feb 20161100
Mar 2016400
Apr 2016400
May 2016600
Jun 2016500
Jul 2016400
Aug 2016400
Sep 20161000
Oct 2016300
Nov 2016800
Dec 2016500
Jan 20171900
Feb 20171000
Mar 20171800
Apr 20171000
May 20171100
Jun 20171200
Jul 2017600
Aug 2017700
Sep 20171300
Oct 2017500
Nov 201712700
Dec 20171300
Jan 2018700
Feb 2018700
Mar 2018400
Apr 2018800
May 20182500
Jun 2018100
Jul 2018100
Aug 2018500
Sep 20182000
Oct 20182500
Nov 2018900
Dec 20181500
Jan 20191900
Feb 2019800
Mar 20191500
Apr 20194200
May 20193400
Jun 20191400
Jul 20192500
Aug 20193200
Sep 20192600
Oct 20191800
Nov 20191700
Dec 20192700
Jan 20202900
Feb 20203100
Mar 20201700
Apr 20203600
May 20203000
Jun 20202700
Jul 20201500
Aug 20202000
Sep 20202300
Oct 20203000
Nov 20201700
Dec 20201400
Jan 20211400
Feb 20212600
Mar 20211700
Apr 20212600
May 20211600
Jun 20211900
Jul 20211400
Aug 20211200
Sep 20212000
Oct 2021700
Nov 20211500
Dec 20211800
Jan 20221000
Feb 20222900
Mar 20221700
Apr 20221700
May 20222700
Jun 20221000
Jul 20221000
Aug 20221500
Sep 20221900
Oct 20222100
Nov 20221200
Dec 20221300
Jan 2023700
Feb 2023500
Mar 20231500
Apr 20231300
May 2023900
Jun 20231700
Jul 20231400
Aug 20231100
Sep 20231600
Oct 20231500
Nov 2023700
Dec 20231600
Jan 20241300
Feb 20242000
Mar 2024600
Apr 20241100
May 20241400
Jun 20241700
Jul 20245500
Aug 20245200
Sep 20243100
Oct 20242300
Nov 20241700
Dec 20244400
Jan 20253400
Feb 20253200
Mar 20252600
Apr 20252200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiation absorbed dose calculation of Lu-177-DOTA-TATE therapy in patients with somatostatin receptor expressing tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiation absorbed dose calculation of Lu-177-DOTA-TATE therapy in patients with somatostatin receptor expressing tumors
Nami Yeyin, Handan Tanyildizi, Emre Demirci, Resit Akyel, Aslan Aygun, Turkay Toklu, Meltem Ocak, Levent Kabasakal, Bedii Kanmaz
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1027;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiation absorbed dose calculation of Lu-177-DOTA-TATE therapy in patients with somatostatin receptor expressing tumors
Nami Yeyin, Handan Tanyildizi, Emre Demirci, Resit Akyel, Aslan Aygun, Turkay Toklu, Meltem Ocak, Levent Kabasakal, Bedii Kanmaz
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1027;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • Nonradioactive analytical methods for quantifying the modification ratio of antibody chelator conjugates (ACCs) with deferroxamine and DOTA
  • Routine production of 18F-fluorcholine
  • Quantitative assessment of Ge-68 breakthrough from a commercial titanium-dioxide based Ge-68/Ga-68 generator
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Dosimetry Posters

  • Radioimmunotherapy with 90Y-DOTA-BC8 (anti-CD45 Antibody): Effect of Spleen Size and Uptake on Bone Marrow Absorbed Dose
  • New fetal doses from 18FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms
  • IDAC star -a standalone program to easy create Monte Carlo voxel simulated customized dose estimations
Show more Special MTA: Dosimetry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire